133 related articles for article (PubMed ID: 1958520)
1. Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones.
Schuurmans AL; Bolt J; Veldscholte J; Mulder E
J Steroid Biochem Mol Biol; 1991; 40(1-3):193-7. PubMed ID: 1958520
[TBL] [Abstract][Full Text] [Related]
2. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.
Veldscholte J; Berrevoets CA; Ris-Stalpers C; Kuiper GG; Jenster G; Trapman J; Brinkmann AO; Mulder E
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):665-9. PubMed ID: 1562539
[TBL] [Abstract][Full Text] [Related]
3. Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors.
Limonta P; Dondi D; Marelli MM; Moretti RM; Negri-Cesi P; Motta M
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):401-5. PubMed ID: 7626487
[TBL] [Abstract][Full Text] [Related]
4. [Androgen regulation of secreted growth factors in prostate carcinoma cell and tumor lines].
Kellner U; Wagner B; Otto U; Voigt KD; Dietel M; Knabbe C
Verh Dtsch Ges Pathol; 1993; 77():124-8. PubMed ID: 7511269
[TBL] [Abstract][Full Text] [Related]
5. Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells.
Carruba G; Leake RE; Rinaldi F; Chalmers D; Comito L; Sorci C; Pavone-Macaluso M; Castagnetta LA
Steroids; 1994 Jul; 59(7):412-20. PubMed ID: 7974525
[TBL] [Abstract][Full Text] [Related]
6. Androgens and transforming growth factor beta modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP).
Schuurmans AL; Bolt J; Mulder E
Mol Cell Endocrinol; 1988 Nov; 60(1):101-4. PubMed ID: 3265111
[TBL] [Abstract][Full Text] [Related]
7. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
[TBL] [Abstract][Full Text] [Related]
8. Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP.
Schuurmans AL; Bolt J; Mulder E
Prostate; 1988; 12(1):55-63. PubMed ID: 3258066
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor-mediated growth and epidermal growth factor receptor induction in the human prostate cell line LNCaP.
Schuurmans AL; Bolt J; Mulder E
Urol Int; 1989; 44(2):71-6. PubMed ID: 2728128
[TBL] [Abstract][Full Text] [Related]
10. Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion.
Schuurmans AL; Bolt J; Veldscholte J; Mulder E
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):849-53. PubMed ID: 2149505
[TBL] [Abstract][Full Text] [Related]
11. Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor.
Grigoryev DN; Long BJ; Njar VC; Brodie AH
J Steroid Biochem Mol Biol; 2000 Dec; 75(1):1-10. PubMed ID: 11179903
[TBL] [Abstract][Full Text] [Related]
12. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor.
Liu XH; Wiley HS; Meikle AW
J Clin Endocrinol Metab; 1993 Dec; 77(6):1472-8. PubMed ID: 8263129
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.
Sehgal I; Bailey J; Hitzemann K; Pittelkow MR; Maihle NJ
Mol Biol Cell; 1994 Mar; 5(3):339-47. PubMed ID: 8049525
[TBL] [Abstract][Full Text] [Related]
14. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids.
Schuurmans AL; Bolt J; Voorhorst MM; Blankenstein RA; Mulder E
Int J Cancer; 1988 Dec; 42(6):917-22. PubMed ID: 3263955
[TBL] [Abstract][Full Text] [Related]
15. Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP.
Langeler EG; van Uffelen CJ; Blankenstein MA; van Steenbrugge GJ; Mulder E
Prostate; 1993; 23(3):213-23. PubMed ID: 7694266
[TBL] [Abstract][Full Text] [Related]
16. Growth factors in steroid-responsive prostatic tumor cells.
Dondi D; Moretti RM; Marelli MM; Motta M; Limonta P
Steroids; 1996 Apr; 61(4):222-5. PubMed ID: 8733005
[TBL] [Abstract][Full Text] [Related]
17. Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth.
Motta M; Dondi D; Moretti RM; Montagnani Marelli M; Pimpinelli F; Maggi R; Limonta P
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):107-11. PubMed ID: 8603030
[TBL] [Abstract][Full Text] [Related]
18. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
[TBL] [Abstract][Full Text] [Related]
20. Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways.
Jones HE; Barrow D; Dutkowski CM; Goddard L; Smith C; Harper ME; Nicholson RI
Prostate; 2001 Sep; 49(1):38-47. PubMed ID: 11550209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]